Fragile X protein in newborn dried blood spots

BMC Medical Genetics

Volumn 15, Issue 1, 2014, Pages

  Adayev, Tatyana ^a   LaFauci, Giuseppe ^a   Dobkin, Carl ^a   Caggana, Michele ^b   Wiley, Veronica ^c   Field, Michael ^d   Wotton, Tiffany ^c   Kascsak, Richard ^a   Nolin, Sarah L ^a   Glicksman, Anne ^a   Hosmer, Nicole ^a   Ted Brown, W ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b WADSWORTH CENTER   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d Hunter Genetics   (Australia)

Author keywords

Capture immune assay; CGG repeats; DBS; Dried blood spots; FMR1; FMRP; Fragile X syndrome; Luminex; Newborn screening

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; FMR1 PROTEIN, HUMAN;

ARTICLE; BLOOD STORAGE; CGG REPEAT; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; MALE; NEW SOUTH WALES; NEW YORK; NEWBORN; NEWBORN SCREENING; RETROSPECTIVE STUDY; TRINUCLEOTIDE REPEAT; BLOOD; GENETICS; PROCEDURES; TIME;

BLOOD PRESERVATION; DRIED BLOOD SPOT TESTING; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84964314859     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/s12881-014-0119-0     Document Type: Article

References (27)

1. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL: Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991, 66(4):817-822.
2. Tassone F, Hagerman RJ, Ikle DN, Dyer PN, Lampe M, Willemsen R, Oostra BA, Taylor AK: FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 1999, 84(3):250-261.
3. De Boulle K, Verkerk AJ, Reyniers E, Vits L, Hendrickx J, Van Roy B, Van den Bos F, de Graaff E, Oostra BA, Willems PJ: A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet 1993, 3(1):31-35.
4. Coffey SM, Cook K, Tartaglia N, Tassone F, Nguyen DV, Pan R, Bronsky HE, Yuhas J, Borodyanskaya M, Grigsby J, Doerflinger M, Hagerman PJ, Hagerman RJ: Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A 2008, 146A(8):1009-1016.
5. Levesque S, Dombrowski C, Morel ML, Rehel R, Cote JS, Bussieres J, Morgan K, Rousseau F: Screening and instability of FMR1 alleles in a prospective sample of 24, 449 mother-newborn pairs from the general population. Clin Genet 2009, 76(6):511-523.
6. Cronister A, Teicher J, Rohlfs EM, Donnenfeld A, Hallam S: Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis. Obstet Gynecol 2008, 111(3):596-601.
7. Nolin SL, Sah S, Glicksman A, Sherman SL, Allen E, Berry-Kravis E, Tassone F, Yrigollen C, Cronister A, Jodah M, Ersalesi N, Dobkin C, Brown WT, Shroff R, Latham GJ, Hadd AG: Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet A 2013, 161A(4):771-778.
8. Seltzer MM, Baker MW, Hong J, Maenner M, Greenberg J, Mandel D: Prevalence of CGG expansions of the FMR1 gene in a US populationbased sample. Am J Med Genet B Neuropsychiatr Genet 2012, 159(5):589-597.
9. Kenneson A, Zhang F, Hagedorn CH, Warren ST: Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 2001, 10(14):1449-1454.
10. Colak D, Zaninovic N, Cohen MS, Rosenwaks Z, Yang WY, Gerhardt J, Disney MD, Jaffrey SR: Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science 2014, 343(6174):1002-1005.
11. Reyniers E, Vits L, De Boulle K, Van Roy B, Van Velzen D, de Graaff E, Verkerk AJ, Jorens HZ, Darby JK, Oostra B, Willems PJ: The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat Genet 1993, 4(2):143-146.
12. LaFauci G, Adayev T, Kascsak R, Kascsak R, Nolin S, Mehta P, Brown WT, Dobkin C: Fragile X screening by quantification of FMRP in dried blood spots by a Luminex immunoassay. J Mol Diagn 2013, 15(4):508-517.
13. Fischer A, Lejczak C, Lambert C, Servais J, Makombe N, Rusine J, Staub T, Hemmer R, Schneider F, Schmit JC, Arendt V: Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in Rwanda. J Clin Microbiol 2004, 42(1):16-20.
14. Chen L, Hadd A, Sah S, Filipovic-Sadic S, Krosting J, Sekinger E, Pan R, Hagerman PJ, Stenzel TT, Tassone F, Latham GJ: An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. J Mol Diagn 2010, 12(5):589-600.
15. Chen L, Hadd AG, Sah S, Houghton JF, Filipovic-Sadic S, Zhang W, Hagerman PJ, Tassone F, Latham GJ: High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses. Genet Med 2011, 13(6):528-538.
16. Grasso M, Boon EM, Filipovic-Sadic S, van Bunderen PA, Gennaro E, Cao R, Latham GJ, Hadd AG, Coviello DA: A Novel Methylation PCR that Offers Standardized Determination of FMR1 Methylation and CGG Repeat Length without Southern Blot Analysis. J Mol Diagn 2014, 16(1):23-31.
17. Naseri M: Alterations of peripheral leukocyte count, erythrocyte sedimentation rate, and C-reactive protein in febrile urinary tract infection. Iran J Kidney Dis 2008, 2(3):137-142.
18. Newman TB, Puopolo KM, Wi S, Draper D, Escobar GJ: Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010, 126(5):903-909.
19. Hagerman RJ, Staley LW, O'Conner R, Lugenbeel K, Nelson D, McLean SD, Taylor A: Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 1996, 97(1):122-126.
20. Godler DE, Tassone F, Loesch DZ, Taylor AK, Gehling F, Hagerman RJ, Burgess T, Ganesamoorthy D, Hennerich D, Gordon L, Evans A, Choo KH, Slater HR: Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. Hum Mol Genet 2010, 19(8):1618-1632.
21. Godler DE, Slater HR, Bui QM, Storey E, Ono MY, Gehling F, Inaba Y, Francis D, Hopper JL, Kinsella G, Amor DJ, Hagerman RJ, Loesch DZ: Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study. Clin Chem 2012, 58(3):590-598.
22. Bailey DB Jr, Armstrong FD, Kemper AR, Skinner D, Warren SF: Supporting family adaptation to presymptomatic and "untreatable" conditions in an era of expanded newborn screening. J Pediatr Psychol 2009, 34(6):648-661.
23. Skinner D, Choudhury S, Sideris J, Guarda S, Buansi A, Roche M, Powell C, Bailey DB Jr: Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project. Pediatrics 2011, 127(6):e1455-1463.
24. Christie L, Wotton T, Bennetts B, Wiley V, Wilcken B, Rogers C, Boyle J, Turner C, Hansen J, Hunter M, Goel H, Field M: Maternal attitudes to newborn screening for fragile X syndrome. Am J Med Genet A 2013, 161A(2):301-311.
25. Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, Warren ST: Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 2009, 85(4):503-514.
26. Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, Nguyen D, Mu LY, Laffin J, Bailey DB, Hagerman RJ: FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 2012, 4(12):100.
27. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ: Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 2004, 291(4):460-469.